HEPS Q1 2026 Earnings Negative EPS and No Revenue Disclosure Weigh on Sentiment Shares Decline 387 Journey Medical Q1 2026 Earnings Narrow EPS Miss as Shares Slide 4 KURA Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates as Pipeline Development Intensifies OSCR Q1 2026 Earnings Profit Surge Surpasses Expectations as Stock Dips VRTS Q1 2026 Earnings EPS Misses Estimates on Negative Surprise Natuzzi SpA NTZ Q4 2011 Earnings Heavy Loss Misses ZeroEstimate as Restructuring Pressures Persist